Analysts have mixed opinions on International Business Machines Corp post Q4 results. BMO Capital analyst Keith Bachman raised the price target on IBM to $155 from $153 (17 percent upside) and reiterated a Market Perform rating. The analyst says he is “a bit more positive” on the company due to the performance of Consulting and his “enthusiasm for services generally.” Still, the ongoing concerns about the durability of software growth keep him on the sidelines. MoffettNathanson analyst Lisa Ellis reiterated a Sell rating on IBM with a $115 price target (13 percent downside). The company’s constant currency revenue growth jumped to 5.1 percent when excluding the benefit from Kyndryl transfers, Ellis notes. IBM’s sales benefit from “two significant tailwinds:” the spin-out of Kyndryl and a robust enterprise IT demand environment, says the analyst. However, Ellis says IBM’s substantial revenue growth improvement is not yet translating to improved profits and free cash flow. She expects IBM to …